sb 203580 has been researched along with Epilepsy, Temporal Lobe in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, J; Li, S; Shang, Y; Shi, J; Wang, M; Yang, W; Zhao, L | 1 |
| Concepcion, FA; D'Ambrosio, R; Fender, J; Jones, TD; Jung, S; Liu, Y; Neumaier, JF; Poolos, NP; Skyrud, DW; Tai, TY; Warner, LN; Williams, AD | 1 |
2 other study(ies) available for sb 203580 and Epilepsy, Temporal Lobe
| Article | Year |
|---|---|
HMGB1-TLR4 Axis Plays a Regulatory Role in the Pathogenesis of Mesial Temporal Lobe Epilepsy in Immature Rat Model and Children via the p38MAPK Signaling Pathway.
Topics: Animals; Animals, Newborn; Cells, Cultured; Child; Enzyme Inhibitors; Epilepsy, Temporal Lobe; Female; HMGB1 Protein; Humans; Imidazoles; Male; MAP Kinase Signaling System; Neurons; p38 Mitogen-Activated Protein Kinases; Pilocarpine; Pyridines; Rats; Rats, Sprague-Dawley; Toll-Like Receptor 4 | 2017 |
Antiepileptic action of c-Jun N-terminal kinase (JNK) inhibition in an animal model of temporal lobe epilepsy.
Topics: Animals; Anisomycin; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Disease Models, Animal; Epilepsy, Temporal Lobe; Imidazoles; JNK Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Pyridines; Rats, Sprague-Dawley; Signal Transduction | 2017 |